National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Featured Clinical Trials

Cancer Studies Highlighted in the NCI Cancer Bulletin
< Back to Main

Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Search by Cancer Type
Breast Cancer

Colon and Rectal Cancer

Lung Cancer

Prostate Cancer

More Featured Trials
Search Featured Trials

    Search  
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Restructuring the NCI Clinical Trials Enterprise

Clinical Trials Reporting Program

Coordinating Center for Clinical Trials

States Requiring Coverage of Clinical Trial Costs
You CAN Quit Smoking Now!
Related Pages
Search for Clinical Trials
NCI's PDQ® Cancer Clinical Trials Registry.

Endometrial Cancer Home Page
NCI's gateway for information about endometrial cancer.
Endometrial Cancer - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

1.  Refining Treatment for High-risk Early Stage Endometrial Cancer
(Posted: 08/14/2009) - In this clinical trial, women with high-risk early stage endometrial cancer will be randomly assigned following surgery to receive one of two types of adjuvant therapy: brachytherapy targeted to the vaginal cuff in combination with chemotherapy or standard pelvic external-beam radiotherapy.

2.  Chemotherapy for Advanced or Recurrent Endometrial Cancer
(Posted: 09/20/2005) - In this trial, researchers will compare two chemotherapy combinations in women with advanced or recurrent endometrial cancer to determine which combination will help patients survive longer. This study is designed to set the standard of care for women with advanced endometrial cancer.

3.  Targeted Combination Therapy for Advanced Solid Tumors
(Posted: 07/19/2005) - In this study, researchers are assessing the safety and combined effectiveness of bevacizumab and a second drug called sorafenib. Both bevacizumab and sorafenib inhibit the formation of blood vessels to tumors and may act synergistically when combined.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov